This website is intended for UK healthcare professionals only and contains promotional content.

Report an adverse event here
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE:Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on the following pages, including but not limited to these Established Medicines. For more information please click here.​

INFORMATION FOR MEMBERS OF THE GENERAL PUBLIC, PATIENTS AND CAREGIVERS

Therapy Areas

Adverse events should be reported: If, as a patient, you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects you can help provide more information on the safety of this medicine. Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard/. Adverse events should also be reported to Grünenthal Ltd. at drugsafety.uk@grunenthal.com

Below are resources you may find helpful. These resources have been created by independent UK organisations and, as such, Grünenthal Meds has no control over their content.



Alcohol Related Brain Damage (ARBD)

Cancer pain

Bone health

Cancer and treatment-related nausea and vomiting

Anal fissure

Average:

This website is for healthcare professionals only.

If you are a registered healthcare professional outside the UK please visit the Grünenthal Meds Website

M-GRM-HQ-11-24-0006 May 2025